Early Diagnosis and Monitoring the Viral Load Phases in SARS Patients by Gene Chip Technology

肖白,王辰,吕月平,谭淑珍,闫梅,丁洁,王臻,刘敬忠,周一鸣,王栋,高华方,陶生策,杜建宇,李泽,蒋迪,张琼,范肖冬,张川,程京,任丽丽,杨仁全,洪涛,王健伟
DOI: https://doi.org/10.3969/j.issn.1671-2870.2004.03.020
2004-01-01
Journal of Diagnostics
Abstract:Objective To provide reference index for early diagnosis of SARS and to monitor the phases of viral load in SARS patients by gene chip technology. Methods Four patients with non-serious SARS were followed up for 30 days. The samples of blood and respiratory tract secretion were collected every 2-6 days for seven times, including 26 EDTA anticoagulated peripheral blood samples and 24 respiratory tract secretion (sputum or nasopharyngeal swab or pharyngeal swab) samples. Four sets of the RT-nested PCR primers and the gene chip probes were designed in SARS-CoV RNA region of coding replicase 1A, spike glycoprotein and nucleocapsid protein. The dUTP/UNG was added to the amplification system for avoiding the contamination. The negative control, the positive control, the blank control and the system internal control were strictly designed in the gene chip. Results SARS-CoV RNA was detected only in the respiratory tract samples collected at day 4 after the onset of symptoms in 2 of 4 patients , the peak viral load with strong or medium positive expressions at day 9-18 was showed in all the samples obtained from the 4 patients and the load dropped at day 18-23 and dispersed at day 22-30 in total samples. Conclusions SARS-CoV detection by gene chip technology may be a use ful reference for early diagnosis and monitoring of the viral load in SARS patients.
What problem does this paper attempt to address?